Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)

Paul Coppo, Michael Bubenheim, Ygal Benhamou, Linus Völker, Paul Brinkkötter, Lucas Kühne, Paul Knöbl, Maria Eva Mingot-Castellano, Cristina Pascual-Izquierdo, Javier de la Rubia, Julio del Rio Garma, Shruti Chaturvedi, Camila Masias, Marshall Mazepa, X. Long Zheng, György Sinkovits, Marienn Réti, Christopher J. Patriquin, Katerina Pavenski, Tiago Boechat, João Farias, Eduardo Flavio Oliveira Ribeiro, Michaela Larissa Lobo de Andrade, Agnès Veyradier, Bérangère Joly, Raïda Bouzid, Kazuya Sakai, Masanori Matsumoto, Pasquale Agosti, Ilaria Mancini, Flora Peyvandi, Eleni Gavriilaki, Matthew Stubbs, Amjad Hmaid, Spero Cataland, Bernhard Lämmle, Marie Scully

Open source

DOI: 10.1016/j.eclinm.2025.103168
Published: 2025-04
Container: eClinicalMedicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2025.103168,
  title = {Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)},
  author = {Paul Coppo and Michael Bubenheim and Ygal Benhamou and Linus Völker and Paul Brinkkötter and Lucas Kühne and Paul Knöbl and Maria Eva Mingot-Castellano and Cristina Pascual-Izquierdo and Javier de la Rubia and Julio del Rio Garma and Shruti Chaturvedi and Camila Masias and Marshall Mazepa and X. Long Zheng and György Sinkovits and Marienn Réti and Christopher J. Patriquin and Katerina Pavenski and Tiago Boechat and João Farias and Eduardo Flavio Oliveira Ribeiro and Michaela Larissa Lobo de Andrade and Agnès Veyradier and Bérangère Joly and Raïda Bouzid and Kazuya Sakai and Masanori Matsumoto and Pasquale Agosti and Ilaria Mancini and Flora Peyvandi and Eleni Gavriilaki and Matthew Stubbs and Amjad Hmaid and Spero Cataland and Bernhard Lämmle and Marie Scully},
  year = {2025},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2025.103168},
  url = {https://doi.org/10.1016/j.eclinm.2025.103168}
}

RIS

TY  - JOUR
TI  - Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
AU  - Paul Coppo
AU  - Michael Bubenheim
AU  - Ygal Benhamou
AU  - Linus Völker
AU  - Paul Brinkkötter
AU  - Lucas Kühne
AU  - Paul Knöbl
AU  - Maria Eva Mingot-Castellano
AU  - Cristina Pascual-Izquierdo
AU  - Javier de la Rubia
AU  - Julio del Rio Garma
AU  - Shruti Chaturvedi
AU  - Camila Masias
AU  - Marshall Mazepa
AU  - X. Long Zheng
AU  - György Sinkovits
AU  - Marienn Réti
AU  - Christopher J. Patriquin
AU  - Katerina Pavenski
AU  - Tiago Boechat
AU  - João Farias
AU  - Eduardo Flavio Oliveira Ribeiro
AU  - Michaela Larissa Lobo de Andrade
AU  - Agnès Veyradier
AU  - Bérangère Joly
AU  - Raïda Bouzid
AU  - Kazuya Sakai
AU  - Masanori Matsumoto
AU  - Pasquale Agosti
AU  - Ilaria Mancini
AU  - Flora Peyvandi
AU  - Eleni Gavriilaki
AU  - Matthew Stubbs
AU  - Amjad Hmaid
AU  - Spero Cataland
AU  - Bernhard Lämmle
AU  - Marie Scully
PY  - 2025
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2025.103168
UR  - https://doi.org/10.1016/j.eclinm.2025.103168
ER  -

APA

Coppo, P., Bubenheim, M., Benhamou, Y., Völker, L., Brinkkötter, P., Kühne, L., Knöbl, P., Mingot-Castellano, M. E., Pascual-Izquierdo, C., Rubia, J. D. L., Garma, J. D. R., Chaturvedi, S., Masias, C., Mazepa, M., Zheng, X. L., Sinkovits, G., Réti, M., Patriquin, C. J., Pavenski, K., Boechat, T., Farias, J., Ribeiro, E. F. O., Andrade, M. L. L. D., Veyradier, A., Joly, B., Bouzid, R., Sakai, K., Matsumoto, M., Agosti, P., Mancini, I., Peyvandi, F., Gavriilaki, E., Stubbs, M., Hmaid, A., Cataland, S., Lämmle, B., & Scully, M. (2025). Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project). eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2025.103168

Source records

crossref · retrieved 2026-09-26T00:41:02.733Z